The trademark application Myriamed was filed by Myriamed GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 21, 2022, and it was registered by office on July 29, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1686154 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue
Cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells
Biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids
Biological preparation for use in cell cultures other than for medical or veterinary use
Biological tissue cultures, other than for medical or veterinary purposes
Biological tissue cultures, other than for medical or veterinary purposes, namely disease models based on engineered tissue or engineered cells.
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations, in particular cells and tissues
Preparations for the renewal and regeneration of organs
Cellular therapy products
Tissue derived from stem cells
Tissue-regenerative pharmaceutical preparations.
The mark was filed in class 9 with Scientific research and laboratory apparatus and Cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue..
The mark was filed in class 42 with following description of goods:
Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields
Biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues
Drug discovery services, in particular drug discovery services based on tissue engineered organ platforms
Scientific and technological services and research in the field of regenerative medicine
Cell culture services for scientific and research purposes, for others.